"Hour-glass" shape of the uterus in the diagnosis and treatment of cervical pregnancy

This study attempts to point out the importance of the anatomo-clinical finding of an "hour-glass" shape to the uterus in the diagnosis and treatment of cervical pregnancy. From 1973 to 2001, four cases of cervical pregnancy were treated in the 2nd Obstetrical and Gynecological Clinic of the Aristotelion University of Salonica. The incidence was 1:13,111 pregnancies (4 cervical in 52,446 pregnancies). Three of the patients underwent bilateral ligation of the anterior trunk of the internal iliac artery using absorbable ligatures. The fourth patient (a 42-year-old), elected to have a hysterectomy. All patients were well and discharged from hospital on the seventh postoperative day. Two of the three patients treated by ligation of the anterior trunk of the internal iliac arteries subsequently had normal pregnancies and deliveries. We lost contact with the third patient. The finding of an "hour-glass" uterine shape was very helpful in the diagnosis of cervical pregnancy. The Aristotelion University of Salonica has found that treatment by ligation of the anterior trunk of the internal iliac arteries is effective, causes no complications, never ends in hysterectomy, and maintains the normal menstrual cycles and reproductive ability of the woman.     

Endocrinology: Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion

Mifepristone (600 mg) in combination with a prostaglandin hasbeen demonstrated to be a safe, acceptable alternative to vacuumaspiration for induction of abortion in the first 9 weeks ofpregnancy. However, the efficacy and side-effects of differentprostaglandins used in combination with mifepristone have notbeen assessed in a randomized trial. In this study, 800 womenseeking an abortion at gestational age 63 days amenorrhoea wererandomized to receive either 0.5 mg gemeprost by vaginal pessary(group I) or 600 µg misoprostol (group II) by mouth –48h after taking 200 mg mifepristone by mouth. The side-effectsand number of complete abortions were used as measures of efficacy.There was no significant difference in the rate of completeabortion between group I [96.7%; 95% confidence interval (CI)94.9–98.5%, n = 391] and group II (94.6%; 95% CI 92.3–96.9,n = 386). It was not possible to assess the outcome with certaintyin the remaining 23 women. However, there were significantlymore ongoing pregnancies in the women who received misoprostolthan in those who received gemeprost (nine versus one, P <0.01) and in eight of these 10 women the gestation was >49days. Fewer women in group II required analgesia than in groupI (48 versus 60%, P < 0.001) although the number requestingopiate was similar in each group (6.9 versus 5.2%, P > 0.4).The incidence of nausea and vomiting after misoprostol (47.8and 21.9% respectively) was higher (P < 0.001) than aftergemeprost (33.9 and 12% respectively). The incidence of infectionand heavy bleeding was low in both groups (<2%) and onlyone woman required blood transfusion. We conclude that the recommendeddose of mifepristone and gemeprost can be reduced without impairingclinical efficacy in pregnancies up to 63 days amenorrhoea.Misoprostol is a safe alternative prostaglandin but has a higherincidence of ongoing pregnancies especially at gestation after49 days amenorrhoea.     

Retrograde migration of glove powder in the human female genital tract

BACKGROUND: This study in humans was undertaken to evaluate earlier results from animal research showing a retrograde migration of glove powder from the vagina into the intra-abdominal cavity. METHODS: One study group was gynaecologically examined with powdered gloves the day before an abdominal hysterectomy and another group 4 days pre-operatively. There were two control groups similarly examined with powder-free gloves. Cell smears were taken from the peritoneal fluid and during the operation further smears were taken from the Fallopian tubes, uterine cavity and cervical canal. RESULTS: Statistically significant differences were found for large starch particles at all locations between the study and control groups examined 1 day pre-operatively. Considering small starch particles, there were significant differences in cervix (P < 0.001), uterus (P < 0.01) and the Fallopian tubes (P < 0.01). The combined results also show significant differences between both large and small starch particles in cervix, uterus and the Fallopian tubes. There were also differences between the study and control groups examined 4 days pre-operatively, but these were not statistically significant except for small and large starch particles in uterus (P < 0.01, P < 0.05) and cervix (P < 0.05, P < 0.05). CONCLUSIONS: This study has pointed out a retrograde migration of starch also in humans after a gynaecological examination with powdered gloves. Consequently, powder or any other potentially harmful substance that can migrate from the vagina should be avoided.     

A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester

BACKGROUND: Misoprostol is an effective agent for pre-operative cervical priming before surgical termination of pregnancy in the first trimester. Previous studies have shown that both oral and vaginal routes are equally effective for such a purpose. This study aimed to compare a new route of sublingual administration to the vaginal route of administration for pre-operative cervical priming in first trimester surgical abortion. METHODS: Eighty women with gestational age <12 weeks were randomized by a computer-generated model to receive 400 micro g of misoprostol either sublingually or vaginally 3 h prior to vacuum aspiration. The primary outcome measure was the degree of cervical dilatation, and secondary outcomes included the force required to dilate the cervix from 3 to 8 mm, intra-operative blood loss and incidence of pre-operative side-effects. RESULTS: There was no significant difference in the baseline cervical dilatation (sublingual: 7.6 +/- 1.3 mm; vaginal: 7.7 +/- 0.73 mm), cumulative force required to dilate the cervix from 3 to 8 mm (sublingual: 9.0 +/- 9.8 N; vaginal: 6.6 +/- 5.4 N) and total blood loss (sublingual: 52.1 +/- 20.2 ml; vaginal: 48.3 +/- 12.3 ml). Pre-operative side-effects were also similar. CONCLUSIONS: Both sublingual and vaginal misoprostol are effective in cervical priming before surgical termination of pregnancy in the first trimester. Sublingual misoprostol has the advantage of being more convenient to administer and may be more suitable for day surgery.     

Limiting factors for cytopathological diagnosis of high-grade squamous intraepithelial lesions: a cytohistological correlation between findings in cervical smears and loop electrical excision procedure.

The present study sought possible factors leading to the cytological diagnosis of atypical squamous cells of uncertain significance (ASCUS) in cases of high-grade squamous intraepithelial lesions (HSIL). Based on retrospective histopathological analysis of loop electrical excision procedure (LEEP) products that diagnosed HSIL, two study groups were randomly selected. The first was consisted of cases with two consecutive Papanicolaou (Pap) smears with the diagnosis of ASCUS. The second (control) group was represented by cases diagnosed as HSIL by cytology. From the Pap smears diagnosed as ASCUS, the sampling limitations was different from control group (P < 0.05). The median size of the largest lesion in each case with ASCUS was 2.66 mm (+/- 1.71 mm). In the control group, the median size of the largest lesion was 5.15 mm (+/-2.58 mm) (P < 0.05). The size of the lesion and sample limitations led patients with cervical intraepithelial neoplasms to be diagnosed as ASCUS for two consecutive times, after a 6-mo period.     

阴道分泌物对尿常规临床检验结果的影响分析及应对措施

目的探讨尿常规临床检验中阴道分泌物对检测结果的影响。方法选取2019年3月—2020年1月我院收治64例妇科疾病患者,随机均分为观察组及对照组,每组32例。给予对照组患者常规尿液收集,观察组患者采用试验法进行尿液收集,对比观察两组患者尿中红细胞、白细胞、上皮细胞及尿蛋白检出率以及尿糖、pH值及尿蛋白质值等指标。结果两组患者尿液中红细胞(χ²=4.010,P=0.045)、上皮细胞(χ²=4.730,P=0.030)、尿蛋白(χ²=4.010,P=0.045)检出率比较差异具有统计学意义(P<0.05),白细胞检出率比较(χ²=0.350,P=0.554)差异无统计学意义(P>0.05);两组尿糖(t=15.031,P=0.000)、蛋白质(t=7.334,P=0.000)、pH值(t=16.724,P=0.000)比较中差异具有统计学意义(P<0.05)。结论阴道分泌物会对尿常规检查结果产生影响,使用试验法进行尿液收集可有效去除阴道分泌物,减少对结果的干扰。     

性病高危人群中女性阴道口部位沙眼衣原体感染的检测

目的 :研究能否用阴道口部位标本代替宫颈标本检测沙眼衣原体 (CT)。方法 :分别用 PCR法和立明法 (Clearview)对 2 31例性病高危人群的宫颈拭子、阴道口拭子及尿液标本进行检测。结果 :以6种检测方法中任何 2种结果同时阳性为金标准 ,宫颈拭子、阴道口拭子及尿液 3种标本 PCR法的敏感性和特异性分别是 86 .8%和 99.4 8% ,84 .2 %和 10 0 % ,6 3.2 %和 99.4 8% ;立明法的敏感性和特异性分别是 81.6 %和 10 0 % ,4 7.4 %和 10 0 % ,10 .5 %和 10 0 %。结论 :对女性 CT检测可以用阴道口拭子代替其它部位标本进行 PCR检测     

药物流产不全延迟处理54例临床分析

目的　探讨药物流产不全的原因及诊治方法。方法　收集药物流产后阴道出血达 1月以上而未行治疗者 ,根据B超等协助诊断 ,予以清宫后治愈。结果　 5 4例全部行清宫术 ,刮出物病检均为机化变性绒毛组织 ,部分伴炎性反应。清宫后阴道出血停止。结论　对于药物流产后阴道出血时间过长者 ,应及早明确诊断 ,及时行清宫术。     

非脱垂子宫经阴道与经腹切除的比较

目的：对非脱垂的良性子宫疾病全子宫切除的不同方法进行评价,以便合理地制定手术方案,方法：非脱垂子宫行阴道全子宫切除（VH）15例,随机选择同期良性子宫疾病行经腹全子宫切除术（TAH）15例,采用对照研究方法,对一般临床资料,手术、术后恢复、住院日和费用等进行对照分析。结果：VH2例中转经腹手术,成功率87％,两组一般临床资料、诊断、子宫大小、麻醉、手术范围、失血量差异无显著性,VH术后无伤痛,用止痛药仅23％,TAH15例均有伤口痛,用止痛药47％,住院日、经费及总费用VH明显少于TAH,两组差异有显著意义（P＝0．0027、0．0447、0．0162）。结论对良性子宫疾病全子切除VH显示的优势特别适合我国国情,大子宫并非手术禁忌,明确VH的禁忌以利于VH在临床推广应用。     

膝胸卧位红光照射联合肛提运动对产后痔急性发作的疗效

目的 探讨膝胸卧位红光照射联合肛提运动对产后痔急性发作的改善效果.方法 将68例经阴道分娩并发产后痔急性发作的产妇按入院时间分为对照组36例、观察组32例.两组产妇产后给予相同的产褥期知识宣教、母婴护理指导等常规护理措施,在此基础上,对照组采用屈膝侧卧位配合红光照射,观察组给予膝胸卧位红光照射联合肛提运动.观察两组产后24 h和产后5d痔疼痛程度、肛周水肿程度、治疗效果、治疗过程舒适度.结果 干预后两组疼痛评分、肛周水肿程度、治疗效果比较,差异有统计学意义(均P＜0.01);两组治疗过程舒适程度差异无统计学意义(P＞0.05).结论 产后痔急性发作的产妇应用膝胸卧位红光照射配合肛提运动能有效减轻产妇疼痛及肛周水肿程度,治疗效果较好.